Related Experiment Videos

Complement component C1r mediated cleavage of the heavy chain of the major histocompatibility class I antigens

H Eriksson1, M H Nissen

  • 1Department of Biotechnology, Lund University, Sweden.

Insights

Activated complement components C1r and C1s cleave MHC class I heavy chains in native configurations. This proteolysis occurs between alpha 2 and alpha 3 domains, with fragments retaining beta 2-microglobulin interaction.

Area of Science:

  • Immunology
  • Proteomics
  • Molecular Biology

Background:

  • The complement system plays a crucial role in innate and adaptive immunity.
  • Major Histocompatibility Complex (MHC) class I antigens present peptides to cytotoxic T lymphocytes.
  • The interaction between complement and MHC molecules is not fully understood.

Purpose of the Study:

  • To investigate the novel cleavage of MHC class I heavy chains by activated complement components C1r and C1s.
  • To determine the specific domains involved in this proteolysis.
  • To assess the impact of MHC class I antigen configuration on complement-mediated cleavage.

Main Methods:

  • Immune precipitation using anti-MHC class I and anti-beta 2-microglobulin antibodies.
  • Concanavalin A (Con A)-Sepharose precipitation followed by SDS-PAGE to characterize fragments.
  • Analysis of cleavage on native versus heat-denatured MHC class I antigens.

Main Results:

  • Activated C1r and C1s, at serum concentrations, cleave the heavy chain of MHC class I antigens.
  • Cleavage is dependent on the native configuration of MHC class I; heat denaturation reduces cleavage.
  • Proteolysis occurs between the alpha 2 and alpha 3 domains of the MHC class I alpha-chain.
  • The resulting alpha 1/alpha 2 fragment remains associated with beta 2-microglobulin.

Conclusions:

  • C1r and C1s possess a previously unrecognized enzymatic activity against MHC class I heavy chains.
  • The native structure of MHC class I is essential for susceptibility to C1r/C1s-mediated cleavage.
  • This interaction suggests a novel regulatory mechanism involving complement and antigen presentation.

Related Concept Videos